Literature DB >> 2833238

Immunological detection of myeloperoxidase in synovial fluid from patients with rheumatoid arthritis.

S W Edwards1, V Hughes, J Barlow, R Bucknall.   

Abstract

We have used rocket immunoelectrophoresis and immunoblotting to detect myeloperoxidase in synovial fluid from patients with rheumatoid arthritis. This protein was enzymatically inactive but its identity as myeloperoxidase was confirmed by comparing its subunit structure with that of the purified enzyme. When neutrophils were stimulated to secrete myeloperoxidase in vitro, a polypeptide with an apparent molecular mass of 62 kDa was detected extracellularly by immunoblotting. Neutrophils isolated from synovial fluid showed a reduced level of this 62 kDa polypeptide but it was detected extracellularly in synovial fluid by immunoblotting. Thus, we conclude that neutrophils in synovial fluid from patients with rheumatoid arthritis have been activated in vivo to secrete myeloperoxidase and propose that the products of this enzyme system can contribute to the tissue damage associated with this disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833238      PMCID: PMC1148818          DOI: 10.1042/bj2500081

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Studies on the subunits of human myeloperoxidase.

Authors:  R L Olsen; C Little
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

2.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

Authors:  W N Burnette
Journal:  Anal Biochem       Date:  1981-04       Impact factor: 3.365

Review 3.  Oxidants from phagocytes: agents of defense and destruction.

Authors:  B M Babior
Journal:  Blood       Date:  1984-11       Impact factor: 22.113

Review 4.  A reevaluation of the roles of the O2-dependent and O2-independent microbicidal systems of phagocytes.

Authors:  P Elsbach; J Weiss
Journal:  Rev Infect Dis       Date:  1983 Sep-Oct

5.  The effect of antiarthritic drugs and related compounds on the human neutrophil myeloperoxidase system.

Authors:  N R Matheson
Journal:  Biochem Biophys Res Commun       Date:  1982-09-16       Impact factor: 3.575

6.  Isolation and properties of human neutrophil myeloperoxidase.

Authors:  N R Matheson; P S Wong; J Travis
Journal:  Biochemistry       Date:  1981-01-20       Impact factor: 3.162

7.  Lipid peroxidation in rheumatoid arthritis: thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients.

Authors:  D Rowley; J M Gutteridge; D Blake; M Farr; B Halliwell
Journal:  Clin Sci (Lond)       Date:  1984-06       Impact factor: 6.124

8.  Biosynthesis, transport and processing of myeloperoxidase in the human leukaemic promyelocytic cell line HL-60 and normal marrow cells.

Authors:  I Olsson; A M Persson; K Strömberg
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

9.  Effect of a specific iron chelating agent on animal models of inflammation.

Authors:  D R Blake; N D Hall; P A Bacon; P A Dieppe; B Halliwell; J M Gutteridge
Journal:  Ann Rheum Dis       Date:  1983-02       Impact factor: 19.103

10.  Multiple forms of myeloperoxidase from human neutrophilic granulocytes: evidence for differences in compartmentalization, enzymatic activity, and subunit structure.

Authors:  S O Pember; R Shapira; J M Kinkade
Journal:  Arch Biochem Biophys       Date:  1983-03       Impact factor: 4.013

View more
  19 in total

1.  Neutrophils from the synovial fluid of patients with rheumatoid arthritis express the high affinity immunoglobulin G receptor, Fc gamma RI (CD64): role of immune complexes and cytokines in induction of receptor expression.

Authors:  J A Quayle; F Watson; R C Bucknall; S W Edwards
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

2.  Inhibition of myeloperoxidase by synovial fluid and serum.

Authors:  B Dularay; C M Yea; C J Elson
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

3.  Activation of the neutrophil myeloperoxidase-H2O2 system by synovial fluid isolated from patients with rheumatoid arthritis.

Authors:  H L Nurcombe; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1991-04       Impact factor: 19.103

4.  Role of myeloperoxidase in intracellular and extracellular chemiluminescence of neutrophils.

Authors:  H L Nurcombe; S W Edwards
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

5.  Neutrophil function in pregnancy and rheumatoid arthritis.

Authors:  I P Crocker; P N Baker; J Fletcher
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

6.  Cytidine deaminase activity in synovial fluid of patients with rheumatoid arthritis: relation to lactoferrin, acidosis, and cartilage proteoglycan release.

Authors:  B Månsson; P Geborek; T Saxne; S Björnsson
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

7.  Neutrophils isolated from the synovial fluid of patients with rheumatoid arthritis: priming and activation in vivo.

Authors:  H L Nurcombe; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

8.  Functions of polymorphonuclear leukocytes in early rheumatoid arthritis.

Authors:  M Leirisalo-Repo; L Paimela; S Koskimies; H Repo
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

9.  Activation of neutrophils by soluble and insoluble immunoglobulin aggregates from synovial fluid of patients with rheumatoid arthritis.

Authors:  J J Robinson; F Watson; M Phelan; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

10.  Low density lipoprotein of synovial fluid in inflammatory joint disease is mildly oxidized.

Authors:  M J James; D van Reyk; K A Rye; R T Dean; L G Cleland; P J Barter; W Jessup
Journal:  Lipids       Date:  1998-11       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.